Overview
Nujsaubnusi Vue is a Gynecologic Oncologist and an Oncologist practicing medicine in Pittsburgh, Pennsylvania.
Dr. Vue is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Vulvar Cancer and Lichen Sclerosus.
She is actively involved in clinical research, co-authoring 6 peer reviewed articles.
Specialties
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
UPMC Magee-Womens Gynecologic Oncology
Dr. Sukumvanich is a specialized surgeon and gynecologic oncologist, specializing in the treatment of gynecologic and breast cancers. He serves as an assistant professor in the School of Medicine, and his research centers on the genetic causes of ovarian and breast cancers, and also cancer informatics (the science of analyzing large amounts of information). Dr. Sukumvanich is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Vaginal Cancer, Vulvar Cancer, Vulvectomy, and Lymphadenectomy. Dr. Sukumvanich is board certified in American Board Of Obstetrics And Gynecology and American Board Of Obstetrics And Gynecology. Dr. Sukumvanich is currently accepting new patients.
AHN Cancer Institute-Med Onc & Infusions At Allegheny General Hospital
Nathan Bahary MD, PhD received his B.A. from Cornell University, an M.D. from the Cornell University School of Medicine, and his Ph.D. from the Rockefeller University. He completed his residency at Beth Israel Hospital in Boston. He did his postgraduate training at the Dana Farber Cancer Institute, Harvard, and Brigham and Women’s Hospital system before joining the faculty of UPMC as the Director of the Pancreatic Cancer Center. Since 2021, he is the Division Chief of Medical Oncology at AHN Cancer Institute and Director of AHNCI Clnical Research. Amongst his various appointments Dr. Bahary is a member of the NCI Pancreatic Task Force, the Eastern Cooperative Oncology Group (ECOG) where he serves on the ECOG GI Steering Committee and the American Society of Clinical Oncology (ASCO) His basic research interests lie in the intersection between gastrointestinal development, metabolic stress pathways, immunology, and cancer. He has a broad research background in cancer genetics, developmental biology, molecular biology, and clinical investigations, with specific training and expertise in key research areas broadly within the field of gastrointestinal oncology, and specifically within pancreatic cancer. Building on his work at Harvard Medical School, Dr. Bahary is using insights gained by studying vertebrate development to determine how cancers grow. Clinical trials emanating from this research will continue at AHN Cancer Institute and are expected to lead to the development of new targeted agents and immunologic strategies for treating cancer. Dr. Bahary is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Neuroendocrine Tumor, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Bahary is board certified in Medical Oncology, American Board Of Internal Medicine.
UPMC Presbyterian
Jason Luke is an Oncologist practicing medicine in Pittsburgh, Pennsylvania. Dr. Luke is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Melanoma, Metastatic Uveal Melanoma, Uveal Melanoma, Melanoma of the Eye, and Liver Embolization.
Office
Leonard Appleman is an Oncologist practicing medicine in Pittsburgh, Pennsylvania. Dr. Appleman is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Prostate Cancer, Familial Prostate Cancer, Chromophobe Renal Cell Carcinoma, and Nephrectomy.
UPMC Magee-Womens Gynecologic Oncology
Jamie Lesnock, MD, specializes in gynecologic oncology and is certified in gynecologic oncology and obstetrics and gynecology by the American Board of Obstetrics and Gynecology. She practices at University of Pittsburgh Physicians, Department of Obstetrics and Gynecology and is affiliated with UPMC Mercy, UPMC Presbyterian, UPMC Shadyside, UPMC Magee-Womens Hospital, and UPMC Passavant. She completed her residency at University of Pittsburgh School of Medicine and her medical degree at Vanderbilt University School of Medicine. Dr. Lesnock is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Endometrial Cancer, Ovarian Cancer, Ovarian Carcinosarcoma, Ureteral Reconstruction, and Tissue Biopsy. Dr. Lesnock is board certified in American Board Of Obstetrics And Gynecology and American Board Of Obstetrics And Gynecology. Dr. Lesnock is currently accepting new patients.
Upmc Division Of Surgical Oncology
Diwakar Davar, MBBS, M.Sc is an assistant professor of medicine and a medical oncologist/hematologist. He specializes in the management of advanced melanoma and the development of early phase studies to test novel immunotherapeutic approaches to treat advanced cancers.;. Dr. Davar is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Metastatic Uveal Melanoma, Uveal Melanoma, and Gamma Knife Radiosurgery. Dr. Davar is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Davar is currently accepting new patients.
Frequently Asked Questions about Dr. Nujsaubnusi C. Vue
Is Dr. Nujsaubnusi C. Vue a top-rated expert for Vulvar Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Nujsaubnusi C. Vue is classified as an Advanced expert for Vulvar Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Nujsaubnusi C. Vue specialize in?
While Dr. Nujsaubnusi C. Vue is a Gynecologic Oncology, they have specific expertise in Vulvar Cancer, Lichen Sclerosus. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Gynecologic Oncology.
Does Dr. Nujsaubnusi C. Vue participate in research or clinical trials?
Yes. Dr. Nujsaubnusi C. Vue has published 6 articles and abstracts on conditions like Vulvar Cancer. You can view a list of Dr. Nujsaubnusi C. Vue's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Nujsaubnusi C. Vue accept my insurance?
Dr. Nujsaubnusi C. Vue accepts most major insurance plans, including Aetna and Cigna. We recommend calling the office directly to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Vulvar CancerDr. Vue isAdvanced. Learn about Vulvar Cancer.
- Experienced
- Lichen SclerosusDr. Vue isExperienced. Learn about Lichen Sclerosus.



